Search

everythinglearnresearchcommunity

for

Search:↓

Avacopan may cause unexpected side effects, so early monitoring is important.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Interferon therapy is a promising and safe treatment for hepatitis B in Southeast Asia.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

Using fat-derived cells to treat hair loss increased hair density and thickness without side effects.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

Cyclosporin A vesicles effectively regrow hair and reduce inflammation in alopecia areata.

The botanical treatment for hair loss shows promise, especially for children.

A woman with severe hair loss was successfully treated with the drug adalimumab.

The combination therapy was effective and well-tolerated, especially in young patients.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Retinoic acid is effective for treating eruptive vellus hair cysts.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.